tiprankstipranks
Company Announcements

TAUNS Laboratories Expands Testing Portfolio with New License

TAUNS Laboratories Expands Testing Portfolio with New License

Tauns Laboratories, Inc. (JP:197A) has released an update.

Discover the Best Stocks and Maximize Your Portfolio:

TAUNS Laboratories, Inc. has signed a license agreement with First Screening Corp. to utilize its electrochemical detection technology for expanding into cardiovascular, renal, and infectious disease testing. This move aligns with TAUNS’ strategy to diversify its offerings beyond respiratory infections, potentially increasing its corporate value through innovative, minimally invasive testing solutions. The collaboration is expected to accelerate product development and enhance TAUNS’ market presence across various healthcare settings.

For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1